Skip to Content

Join the 'Maxolon' group to help and get support from people like you.

Maxolon News

Popular Morning Sickness Drug Safe in Pregnancy, Study Finds

Posted 15 Oct 2013 by Drugs.com

TUESDAY, Oct. 15 – The anti-nausea medication metoclopramide appears to be a safe and effective treatment for morning sickness, Danish researchers report. More than 40,000 women exposed to metoclopramide while pregnant did not face any increased risk of birth defects or miscarriage, according to a study published Oct. 16 in the Journal of the American Medical Association. "This is by far the largest study on metoclopramide safety in pregnancy, and as such it expands substantially on the published evidence," said co-author Dr. Bjorn Pasternak of the Statens Serum Institute in Copenhagen. "It found that metoclopramide use in pregnancy was not associated with increased risk of major adverse outcomes, including major malformations and fetal death, and as such supports what is known about the safety profile of this drug." More than half of pregnant women experience nausea and vomiting, ... Read more

Related support groups: Reglan, Metoclopramide, Nausea/Vomiting of Pregnancy, Maxolon

FDA Medwatch Alert: Metoclopramide Injection And Ondansetron Injection by Hospira: Recall - Glass Strand Particulates Caused By Glass Supplier

Posted 3 Oct 2013 by Drugs.com

ISSUE: Hospira, Inc. announced it initiated a voluntary nationwide recall of one lot of Metoclopramide Injection, USP, 10 mg/2 mL (5 mg/mL)and two lots of Ondansetron Injection, USP, 4 mg/2 mL, (2 mg/mL). This action is due to a confirmed vial defect where glass particulate matter (glass strands) were identified as being affixed to the inside of the vial walls. There is potential for the glass particulates to dislodge into the solution. To date, Hospira has not received reports of any adverse events associated with this issue for these lots. BACKGROUND: Metoclopramide Injection, USP, 10 mg/2 mL (5 mg/mL), NDC 0409-3414-01, Lot 28-104-DK (the lot number may be followed by a 01), is packaged in a 2 mL single-dose fliptop vial, with an expiration date of October 1, 2014. Ondansetron Injection, USP, 4 mg/2 mL (2 mg/mL), NDC 0409-4755-03, Lots 29-484-DK and 29-510-DK (the lot numbers may be f ... Read more

Related support groups: Nausea/Vomiting, Zofran, Reglan, Ondansetron, Metoclopramide, Zofran ODT, Maxolon, Zuplenz

Most Medications OK During Breast-Feeding, Report Says

Posted 26 Aug 2013 by Drugs.com

MONDAY, Aug. 26 – Most breast-feeding moms can safely take the medications and vaccines they need, without fear they'll harm a nursing infant, according to a new report from a leading group of U.S. pediatricians. The report, from the American Academy of Pediatrics in consultation with the U.S. Food and Drug Administration, describes proposed changes to drug labels. The new labels would replace the current "Nursing Mothers" section with a heading called "Lactation," which would give much more detailed information about a drug's transfer to breast milk and potential to harm a breast-fed baby. The proposed changes are part of a push by the FDA to require drug makers to study how medications may affect breast-feeding and to better communicate that information to women and their doctors. "Because we know that breast-feeding has both developmental and health benefits for the mom and the ... Read more

Related support groups: Oxycodone, Zoloft, OxyContin, Sertraline, Tylenol, Ibuprofen, Naproxen, Acetaminophen, Advil, Roxicodone, Aleve, Paracetamol, Motrin, Reglan, Metoclopramide, Propoxyphene, Panadol, Darvon, Naprosyn, Paracetamol Teva

Most Pregnant Women Treated for Migraines Able to Deliver Vaginally

Posted 30 Jun 2013 by Drugs.com

FRIDAY, June 28 – Most pregnant women who were hospitalized and treated for acute severe migraines had vaginal births of full-term babies, a small new study finds. Nearly 76 percent of the patients had full-term vaginal deliveries and about 17 percent had preterm deliveries. The rate of preterm delivery in the general population is about 11 percent. Follow-up was not possible for about 7 percent of the patients. Participants included 29 patients who were an average of 27.5 weeks pregnant when they were treated in a hospital for migraines. Treatments included: acetaminophen (Tylenol) by mouth (79 percent); intravenous metoclopramide (59 percent); a combination of the two (55 percent); oral or IV narcotic (34 percent); acetaminophen, butalbital and caffeine (24 percent); and IV magnesium sulfate (7 percent). Ten percent of patients needed more pain relief and were treated with peripheral ... Read more

Related support groups: Migraine, Tylenol, Acetaminophen, Paracetamol, Fioricet, Reglan, Metoclopramide, Panadol, Paracetamol Teva, Esgic, Tylenol Extra Strength, Acetaminophen/Butalbital/Caffeine, Esgic-Plus, Dolgic Plus, Tylenol Arthritis Caplet, Q-Pap, Panadol Osteo, Childrens Tylenol, Perfalgan, Acetaminophen Quickmelt

FDA Medwatch Alert: Olympia Pharmacy Sterile Compounded Products: Recall - Concerns About Sterility Assurance

Posted 5 Jun 2013 by Drugs.com

  [Posted 05/30/2013] ISSUE: Lowlite Investments d/b/a Olympia Pharmacy ("Lowlite") notified the public of a voluntary multi-state recall of all sterile drug products compounded by the pharmacy that have not reached the expiration date listed on the product. The recall is being initiated due to concerns associated with prior quality control procedures that impacted sterility assurance. In the event a sterile product is compromised patients are at risk for serious and possible life threatening infections. The recall includes all sterile products that Olympia Pharmacy supplied to patients and offices of licensed medical professionals with a use by date of 09/25/2013 or earlier. Olympia Pharmacy will be notifying customers by phone, fax, or mail to return the products to the pharmacy. BACKGROUND: To date, Lowlite has received no reports of injury or illness associated with the use of the a ... Read more

Related support groups: Provera, Depo-Provera, Subutex, Estradiol, Meloxicam, Testosterone, Methylprednisolone, Butrans, AndroGel, Medroxyprogesterone, Mobic, Buprenorphine, Estrace, Medrol, Testim, Reglan, Vivelle, Axiron, Climara, Atropine

Many Primary Care Docs Don't Know Long-Term Effects of Chemo: Survey

Posted 16 May 2012 by Drugs.com

WEDNESDAY, May 16 – Many primary care doctors don't know the long-term side effects of the chemotherapy treatments that cancer survivors under their care may have been given, a new survey found. On the other hand, most oncologists – though not all – are familiar with the side effects of four common treatments used to treat breast and colon cancer, according to the results of the survey being presented at the upcoming annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago. "While oncologists commonly identify the main late effects of four common cancer drugs, primary care providers did not," study author Dr. Larissa Nekhlyudov said during a Wednesday news conference. "This is not surprising in that primary care providers have different training and exposure to chemotherapy drugs," she noted. "However, these findings emphasize that in the transition of patients ... Read more

Related support groups: Cancer, Zyprexa, Olanzapine, Reglan, Metoclopramide, Nausea/Vomiting - Chemotherapy Induced, Taxol, Cytoxan, Zyprexa Zydis, Cyclophosphamide, Oxaliplatin, Paclitaxel, Doxorubicin, Adriamycin, Zyprexa Intramuscular, Eloxatin, Maxolon, Adriamycin PFS, Neosar, Adriamycin RDF

Morning Sickness Drug Gets Green Light in Study

Posted 10 Jun 2009 by Drugs.com

WEDNESDAY, June 10 – A new study suggests that women who experience morning sickness early in pregnancy can safely take the medication metoclopramide to relieve their symptoms. The study, which included nearly 3,500 pregnant women who took metoclopramide (Reglan), a drug developed to treat gastrointestinal (GI) problems, found no significant increases in the risk of birth defects, premature delivery, low birth weight or fetal death. "It appears that metoclopramide is safe for short-term use to control GI problems in pregnant women when used as prescribed," said the study's senior author, Amalia Levy, a senior lecturer in epidemiology at Ben-Gurion University of the Negev in Israel. "Physicians are reassured about the safety of metoclopramide use in pregnancy in recommended doses." Results of the study appear in the June 11 issue of the New England Journal of Medicine. In Europe and in ... Read more

Related support groups: Maxolon

Ask a Question

Further Information

Related Condition Support Groups

Nausea / Vomiting, Gastroparesis, Migraine, GERD, Small Intestine Intubation, Radiographic Exam, Nausea / Vomiting - Chemotherapy Induced, Nausea / Vomiting - Postoperative

Maxolon Patient Information at Drugs.com